chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: RSV
Symptoms: Exposure during pregnancy, Product administered to patient of inappropriate age
Clinical narrative: pregnant patient of unknown gestation received Arexvy; 26 year old female patient received Arexvy vaccine; This non-serious prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 26-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number MY2LE, expiry date 26-MAR-2025) for prophylaxis.   On 27-JAN-2024, the patient received Arexvy. On 27-JAN-2024, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: 26 year old female patient received Arexvy vaccine). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: pregnant patient of unknown gestation received Arexvy). The outcome of the inappropriate age at vaccine administration and vaccine exposure during pregnancy were unknown.   Pregnancy exposure: Pregnancy Exposure (Arexvy): Trimester unknown Pregnancy Outcome: Pregnancy was ongoing   Additional Information: GSK Receipt Date: 30-JAN-2024  The pharmacist reported that the pregnant patient of unknown gestation received Arexvy vaccine which led to vaccine exposure during pregnancy. The 26 year female patient received Arexvy vaccine which led to Inappropriate age at vaccine administration. There were no symptoms reported. The reporter consented to follow up
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal rigidity, Facial spasm, Muscle spasms, Oesophageal spasm
Clinical narrative: Abdominal, Esophageal, Groin, Mouth Facial and frontal Lobe; Uncontrolled Erratic  Spasm
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Injected limb mobility decreased, Pain in extremity, Product administered at inappropriate site
Clinical narrative: Patient reported that the vaccines she was given were given too high, not in the deltoid muscle.  This caused her arms to be extremely sore and was unable to raise her arms completely for months. She just reported it 2-6-24 when she came to get another vaccination. She stated her symptoms were 80% better and just didn't want this to happen again.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired by 4 days when given to patient
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: After injection she had sharp pains in her head about every 1/2 hour while laying down.  The second day was intermittent (same pains), and by the 3rd day it had resolved.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT VACCINATED AFTER VIABILITY DATE
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Biopsy thyroid gland, Catheterisation cardiac, Computerised tomogram head, Computerised tomogram neck
Clinical narrative: Four days after receiving my vaccination I experienced a severe 'head event'.  While seated comfortably in a chair in an office appointment, I felt a sudden, extreme sensation of pressurization from inside the base of my throat up through the inside of my whole head.  The sensation was dynamic, feeling as though my throat and head were being pumped up rapidly by an air pump.  The pain in my head was excruciating and pressure in my throat was alarming.  My blood pressure, normally unremarkable, was 180/111 and the following morning I went to ER.  Head and neck CTs, head MRI and lumbar puncture ruled out aneurysm, subarachnoid hemorrhage, stroke, and disseminated lung disease. Subsequent testing ruled out thyroid disorder and cancer, cardiovascular event.  Following the event, I continued to experience head pressure and headache for two months, gradually decreasing over time.  I also have been left with labile hypertension and am now taking daily amlodipine.  My preexisting tinnitus has been exacerbated and is worse than prior to the event.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Head discomfort, Headache, Labile hypertension, Lumbar puncture
Clinical narrative: Four days after receiving my vaccination I experienced a severe 'head event'.  While seated comfortably in a chair in an office appointment, I felt a sudden, extreme sensation of pressurization from inside the base of my throat up through the inside of my whole head.  The sensation was dynamic, feeling as though my throat and head were being pumped up rapidly by an air pump.  The pain in my head was excruciating and pressure in my throat was alarming.  My blood pressure, normally unremarkable, was 180/111 and the following morning I went to ER.  Head and neck CTs, head MRI and lumbar puncture ruled out aneurysm, subarachnoid hemorrhage, stroke, and disseminated lung disease. Subsequent testing ruled out thyroid disorder and cancer, cardiovascular event.  Following the event, I continued to experience head pressure and headache for two months, gradually decreasing over time.  I also have been left with labile hypertension and am now taking daily amlodipine.  My preexisting tinnitus has been exacerbated and is worse than prior to the event.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Oropharyngeal discomfort, Tinnitus, Ultrasound thyroid
Clinical narrative: Four days after receiving my vaccination I experienced a severe 'head event'.  While seated comfortably in a chair in an office appointment, I felt a sudden, extreme sensation of pressurization from inside the base of my throat up through the inside of my whole head.  The sensation was dynamic, feeling as though my throat and head were being pumped up rapidly by an air pump.  The pain in my head was excruciating and pressure in my throat was alarming.  My blood pressure, normally unremarkable, was 180/111 and the following morning I went to ER.  Head and neck CTs, head MRI and lumbar puncture ruled out aneurysm, subarachnoid hemorrhage, stroke, and disseminated lung disease. Subsequent testing ruled out thyroid disorder and cancer, cardiovascular event.  Following the event, I continued to experience head pressure and headache for two months, gradually decreasing over time.  I also have been left with labile hypertension and am now taking daily amlodipine.  My preexisting tinnitus has been exacerbated and is worse than prior to the event.
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Paraesthesia oral
Clinical narrative: pt presented to clinic for routine flu shot, no known med allergy or allergy to components to the vaccines were confirmed at time of administration. Approximately 15 mins later pt returned to clinic stating that her lips and tongue feels tingly, the she stated that she felt dizzy. Pt was then given 50mg diphenhydramine, IM and vitals were collected- they were within normal limits. Dr was consulted whether to proceed with Epinephrine treatment, but pt status changed to feeling better with tingling sensation and dizziness subsiding. Pt was then monitored for 30 minutes, with no adverse changes.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT VACCINATED AFTER VIABILITY DATE
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Finally!!!!!  I had positive Covid test on Jan 31 , 15 days post vaccine
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT VACCINATED AFTER VIABILITY DATE.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT VACCINATED AFTER VIABILITY DATE
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT VACCINATED AFTER VIABILITY DATE
Age: 40.0
Sex: M
Vaccine: HEP, TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received expired Hepatitis vaccine. Expiration date 12/3/2023. No noted adverse side effects. Physician aware, recommended series start over.
Age: 12.0
Sex: F
Vaccine: COVID19, FLU4, HPV9
Symptoms: Erythema, Injection site nodule, Peripheral swelling
Clinical narrative: Right arm is red, swollen. She has more of a 'knot' near the injection site.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blindness unilateral, Gait disturbance, Optic ischaemic neuropathy, Vertigo
Clinical narrative: Received vacinne from pharmacy in pm on 10/21/22 and in the middle of the night woke up to go to the bathroom and had severe vertigo. I almost couldn't walk to the bathroom. This continued throughout the next day and eventually subsided. Developed NAION on 4/28/2023. Lost 50% of my VF in L eye. Reported vertigo verbally to Dr. at Clinic.
Age: 63.0
Sex: F
Vaccine: FLUA4
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: 63 year old patient ordered Fluarix vaccine but administered Fluad vaccine. No adverse events noted.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: PATIENT WAS DO TO GET COVID 5-11 YR .3 ML BUT PATIENT RECEVIED UNDILUTED COVID 6 M -4 YR .3 ML PATIENT HAS NOT REPORTED ANY SYMPTOMS
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, COVID-19, Cardiolipin antibody positive, Cytogenetic analysis, Deep vein thrombosis
Clinical narrative: MODERNA 1ST SHOT 3/5/2021 MODERNA SECOND SHOT 4/2/2021, VACCINE FAILURE COVID-19 ILLNESS1/7/2022  LEFT LEG DVT 12/1/2022 ANTICARDIOLIPIN ANTIBODY POSITIVE ANTIBODIES AGAINS SPIKE > 25,000 NEGATIVE AGAINST NUCLEOCAPSID 10/18/2023.  EXAM FOUND SHINGLES UPPER RIGHT CHEST, TACHYCARDIA, HYPERDYNAMIC.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram, Herpes zoster, Tachycardia, Ultrasound Doppler
Clinical narrative: MODERNA 1ST SHOT 3/5/2021 MODERNA SECOND SHOT 4/2/2021, VACCINE FAILURE COVID-19 ILLNESS1/7/2022  LEFT LEG DVT 12/1/2022 ANTICARDIOLIPIN ANTIBODY POSITIVE ANTIBODIES AGAINS SPIKE > 25,000 NEGATIVE AGAINST NUCLEOCAPSID 10/18/2023.  EXAM FOUND SHINGLES UPPER RIGHT CHEST, TACHYCARDIA, HYPERDYNAMIC.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: PATIENT WAS DO TO GET COVID 5-11 YR .3 ML BUT PATIENT RECEVIED UNDILUTED COVID 6 M -4 YR .3 ML PATIENT HAS NOT REPORTED ANY SYMPTOMS
Age: 62.0
Sex: M
Vaccine: SMALL
Symptoms: Blood thyroid stimulating hormone decreased, Graves' disease, Hyperthyroidism, Thyroid stimulating immunoglobulin, Thyroxine free increased
Clinical narrative: Vaccine resulted in development of Grave's disease/thyrotoxicosis
Age: 62.0
Sex: M
Vaccine: SMALL
Symptoms: Tri-iodothyronine free
Clinical narrative: Vaccine resulted in development of Grave's disease/thyrotoxicosis
Age: 20.0
Sex: M
Vaccine: RAB
Symptoms: Dyspnoea
Clinical narrative: Patient reported having shortness of breath and difficulty catching his breath starting about 30 minutes about vaccination.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, FLUC4, PNC15, RV5
Symptoms: Pyrexia, Seizure
Clinical narrative: Patient had a 105 fever, Seizure.
Age: 24.0
Sex: U
Vaccine: FLUN4
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccines was expired. no reactions noted.
Age: 35.0
Sex: F
Vaccine: HEP, MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: wrong immunization given. No adverse effects noted.
Age: 0.33
Sex: U
Vaccine: PNC20, RV1, UNK, UNK
Symptoms: Cyanosis, Influenza virus test negative, Irritability, Pyrexia
Clinical narrative: day of vaccines, 837pm  fever 101.2, fussy.. 904pm , hands turning blueish purple, sent to ED - flu neg. next morning 842 am 102.4 tylenol
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Condition aggravated, Magnetic resonance imaging, Visual snow syndrome
Clinical narrative: VSS symptoms worsen with every vaccination
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cardiac flutter, Diarrhoea, Fatigue, Headache
Clinical narrative: Heart fluttering, pounding heart for first 2 weeks after injection, continues now but less significant. Fatigue, tiredness, night sweats since the injection. Muscle and joint pain-intense and this has not gone away. Headaches, those are lessening in frequency and intensity. Loose stool, diarrhea since the injection.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Palpitations
Clinical narrative: Heart fluttering, pounding heart for first 2 weeks after injection, continues now but less significant. Fatigue, tiredness, night sweats since the injection. Muscle and joint pain-intense and this has not gone away. Headaches, those are lessening in frequency and intensity. Loose stool, diarrhea since the injection.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiomyopathy, Echocardiogram abnormal
Clinical narrative: Patient developed Cardiomyopathy 2 months after receiving her 5th Moderna vaccine
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient was given a dose of 0.25 mL of COVID Moderna 12 and over vaccine.
Age: 1.33
Sex: M
Vaccine: HIBV
Symptoms: Product preparation error
Clinical narrative: The ActHib vaccine was reconstituted with a 0.7% sterile diluent instead of the 0.4 % sterile diluent  that is supplied with the ActHib vaccine.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, FLU4, HEP, MMR, PNC20, RV5
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given an adult dose of Hepatitis B Vaccine. No adverse side effects noted expected per PCP.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Cerebral haemorrhage, Immune thrombocytopenia, Immunoglobulin therapy, Impaired work ability, Platelet transfusion
Clinical narrative: patient was hospitalized about 8 days after vaccine, was diagnosed with ITP, had brain bleed as result, was given platlets, IGG. He had a seizure as a result of brain bleed. patient cannot work to do brain bleeed
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Seizure
Clinical narrative: patient was hospitalized about 8 days after vaccine, was diagnosed with ITP, had brain bleed as result, was given platlets, IGG. He had a seizure as a result of brain bleed. patient cannot work to do brain bleeed
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Back pain, Electric shock sensation, Injection site pain, Injection site swelling, Neck pain
Clinical narrative: PATIENT REPORTS HE RECEIVED SHINGLES VACCINE 1/23/2024 AND WITHIN 12 HOURS STARTED HAVING PAIN IN THE RIGHT ARM AND WITHIN SEVERAL HOURS WITH PAIN THAT WENT UP INTO HIS NECK ON THE RIGHT SIDE. HE REPORTED IT WASN'T HORRIBLE BUT AS THE DAYS PASSED IT CONTINUED TO WORSEN AND STARTED WITH SOME SHOOTING PAIN. HE FOUND THAT IT HURT MORE WHEN STANDING AS WELL, DECREASED SLEEP DUE TO THE PAIN, HE HAD BEEN SEEING A CHIROPRACTOR FOR NECK AND BACK PAIN AND WAS DONE WITH TREATMENTS BUT WHEN PAIN STARTED HE DID GO SEE THE CHIROPRACTOR THINKING IT MIGHT BE HIS NECK AND THE CHIROPRACTOR SAID IT WAS NOT HIS NECK, IT HAD TO DO WITH THE SHOT HE HAD RECEIVED. THE CHIROPRACTOR DID NOT DO ANY TREATMENTS AT THAT TIME AND TOLD PATIENT HE MIGHT HAVE SIRVA AND TO CONTACT HIS PCP. PATIENT WAS SEEN TODAY AND WAS HAVING INCREASED PAIN RIGHT DELTOID WITH SOME SWELLING AND THE PAIN RADIATED UP INTO THE SHOULDER AND INTO THE NECK. HIS SHOULDER HEIGHTS WERE UNEQUAL DUE TO THE WAY HE WAS LETTING HIS ARM HANG. HAD INCREASED PAIN WITH MOVEMENT OF THE RIGHT ARM AS WELL. HE REPORTS THE FEELING OF PAIN WAS A SHOOTING/SHOCK SENSATION. DURING EXAM, HE DID PULL AWAY WHEN PALPATING THE RIGHT DELTOID AND UP INTO THE TOP OF THE SHOULDER/TRAPEZIUS MUSCLE. RECOMMENDED HEAT THERAPY, ARM SLING SO ARM WAS NOT DANGLING, AND GAVE PREDNSONE AND TRAMADOL; FOLLOW UP 7-10 DAYS
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity, Sleep disorder
Clinical narrative: PATIENT REPORTS HE RECEIVED SHINGLES VACCINE 1/23/2024 AND WITHIN 12 HOURS STARTED HAVING PAIN IN THE RIGHT ARM AND WITHIN SEVERAL HOURS WITH PAIN THAT WENT UP INTO HIS NECK ON THE RIGHT SIDE. HE REPORTED IT WASN'T HORRIBLE BUT AS THE DAYS PASSED IT CONTINUED TO WORSEN AND STARTED WITH SOME SHOOTING PAIN. HE FOUND THAT IT HURT MORE WHEN STANDING AS WELL, DECREASED SLEEP DUE TO THE PAIN, HE HAD BEEN SEEING A CHIROPRACTOR FOR NECK AND BACK PAIN AND WAS DONE WITH TREATMENTS BUT WHEN PAIN STARTED HE DID GO SEE THE CHIROPRACTOR THINKING IT MIGHT BE HIS NECK AND THE CHIROPRACTOR SAID IT WAS NOT HIS NECK, IT HAD TO DO WITH THE SHOT HE HAD RECEIVED. THE CHIROPRACTOR DID NOT DO ANY TREATMENTS AT THAT TIME AND TOLD PATIENT HE MIGHT HAVE SIRVA AND TO CONTACT HIS PCP. PATIENT WAS SEEN TODAY AND WAS HAVING INCREASED PAIN RIGHT DELTOID WITH SOME SWELLING AND THE PAIN RADIATED UP INTO THE SHOULDER AND INTO THE NECK. HIS SHOULDER HEIGHTS WERE UNEQUAL DUE TO THE WAY HE WAS LETTING HIS ARM HANG. HAD INCREASED PAIN WITH MOVEMENT OF THE RIGHT ARM AS WELL. HE REPORTS THE FEELING OF PAIN WAS A SHOOTING/SHOCK SENSATION. DURING EXAM, HE DID PULL AWAY WHEN PALPATING THE RIGHT DELTOID AND UP INTO THE TOP OF THE SHOULDER/TRAPEZIUS MUSCLE. RECOMMENDED HEAT THERAPY, ARM SLING SO ARM WAS NOT DANGLING, AND GAVE PREDNSONE AND TRAMADOL; FOLLOW UP 7-10 DAYS
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Angiogram, Blood test, Brain fog, Electroencephalogram
Clinical narrative: Fatigue, brain fog, internal jitters (first few days after and ongoing.  Weight loss >30 pounds in first 6 weeks and ongoing.  Nausea and vomiting within first few days and ongoing (vomiting has decreased).  Episodes of amnesia (x3-4).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling jittery, Magnetic resonance imaging, Nausea, Vomiting
Clinical narrative: Fatigue, brain fog, internal jitters (first few days after and ongoing.  Weight loss >30 pounds in first 6 weeks and ongoing.  Nausea and vomiting within first few days and ongoing (vomiting has decreased).  Episodes of amnesia (x3-4).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Fatigue, brain fog, internal jitters (first few days after and ongoing.  Weight loss >30 pounds in first 6 weeks and ongoing.  Nausea and vomiting within first few days and ongoing (vomiting has decreased).  Episodes of amnesia (x3-4).
Age: 72.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Neck pain
Clinical narrative: Started the next day, pain in the upper left shoulder by the injection site, dull ache.  The pain has since moved to the neck a month later. Tried Mobic (meloxicam) Prednisone and is currently in Physical therapy.
Age: 48.0
Sex: M
Vaccine: HPV9, PNC20
Symptoms: No adverse event, Wrong product administered
Clinical narrative: The medical provider ordered Prevnar 20 and ordered the Hep B vaccination at the visit on 2/8/24. The Medical Assistant administered the Prevnar 20 vaccination. However, the Medical Assistant incorrectly administered HPV vaccine instead of the Hep V vaccination.  The provider states that there is no contraindication to the patient receiving the HPV vaccination and there was no harm done to the patient.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Injection site pain
Clinical narrative: Flu-like symptoms (Muscle aches, chills, fatigue, headache), soreness and swelling at injection site. Symptoms bad for 24 hours (Tues night through Wed night)  then began to subside. Milder symptoms today, Thursday
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site swelling, Myalgia
Clinical narrative: Flu-like symptoms (Muscle aches, chills, fatigue, headache), soreness and swelling at injection site. Symptoms bad for 24 hours (Tues night through Wed night)  then began to subside. Milder symptoms today, Thursday
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Abdominal pain, Chills, Decreased appetite, Diarrhoea
Clinical narrative: headache for 3 days, shivering for 3 days, sharp abdominal pains for 1 week, loss of appetite for 2 weeks, nausea for 2 weeks, upset stomach for 2 weeks, loose stools for 1 week, lethargy for 3 weeks.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Lethargy, Nausea
Clinical narrative: headache for 3 days, shivering for 3 days, sharp abdominal pains for 1 week, loss of appetite for 2 weeks, nausea for 2 weeks, upset stomach for 2 weeks, loose stools for 1 week, lethargy for 3 weeks.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aplastic anaemia, Contusion, Platelet count decreased
Clinical narrative: Platelets dropped to 5,000.  Pt. didn't know until he developed strange bruising.  Took several months to diagnose him with aplastic anemia
Age: 63.0
Sex: F
Vaccine: HEPA
Symptoms: Immunisation, Underdose
Clinical narrative: PATIENT RECEIVED FIRST DOSE IN SERIES OF HAVRIX 1440U/ML ON  08/08/23. PATIENT CAME IN ON 02/05/2024 FOR THE SECOND DOSE IN THE SERIES AND RECEIVED HAVRIX 720U/0.5ML (PEDIATRIC DOSE) IN ERROR. CORRECT DOSE OF HAVRIX 1440U/ML WAS GIVEN ON 02/07/24.
Age: 32.0
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: It was noted post vaccination that while the expiration date on the diluent was 2/2025, the conjugate had an expiration date of 1/31/2024 which is 8 days prior to the vaccination. The patient and the patient's provider were notified and revaccination will occur in the near future. There are no noted adverse reactions from the vaccination and will follow up with the patient over the next few days to ensure no reactions develop.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Induration, Injection site induration, Injection site reaction, Injection site warmth, Peripheral swelling
Clinical narrative: Mother called approximately 1 hour after vaccine administrating reporting a "splotchy dark red" rash spanning the entire arm that received the vaccination. patient himself reported mild swelling of this arm, that the red areas felt slightly firm, and that the red areas felt warmer than his other arm. I spoke to the patient at end of day and he reported rash had improved. he had no systemic symptoms. He previously had received dTap.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Rash, Rash erythematous, Rash macular, Skin warm
Clinical narrative: Mother called approximately 1 hour after vaccine administrating reporting a "splotchy dark red" rash spanning the entire arm that received the vaccination. patient himself reported mild swelling of this arm, that the red areas felt slightly firm, and that the red areas felt warmer than his other arm. I spoke to the patient at end of day and he reported rash had improved. he had no systemic symptoms. He previously had received dTap.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: The morning after vaccination I was having pruritus to the injection site. I noticed in the mirror a half dollar size raised red area. By that night, I was having pruritus all over my body, especially itchy to right rear shoulder/back. Noted to have red discoloration w/o vesicles on those areas. I was unable to sleep d/t the intense pruritus, so I took some Benadryl since that was all I had available. Red areas have since gone away but do have some intermittent itching still. I am trying to keep covered, especially the injection site d/t having a baby at home.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Sleep disorder
Clinical narrative: The morning after vaccination I was having pruritus to the injection site. I noticed in the mirror a half dollar size raised red area. By that night, I was having pruritus all over my body, especially itchy to right rear shoulder/back. Noted to have red discoloration w/o vesicles on those areas. I was unable to sleep d/t the intense pruritus, so I took some Benadryl since that was all I had available. Red areas have since gone away but do have some intermittent itching still. I am trying to keep covered, especially the injection site d/t having a baby at home.
Age: 15.0
Sex: F
Vaccine: TD
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt received Td before the six month mark. Pt received one DTP in 2013. Tdap was given on 12/03/2023. I had based giving Td off of the dose of Tdap since the series of DTP was not fully completed.  Pt has been notified about invalid timeframe and will receive Td in 6 months. I have referred back to the references and resources discussing dosages. I have printed new forms with time frames that breaks down each dose.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Magnetic resonance imaging, Pain in extremity, X-ray
Clinical narrative: sore arm later that day, got worse within a week and then spread to both sides of my arm  with pain down to wrist, then stayed on left shoulder up to neck
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Feeling cold, Pain in extremity, Tremor
Clinical narrative: PATIENT STATES HAVING PAIN IN HER ARM OF THE INJECTION.  SHE STATES HAVING RIGORS. ALSO BEING COLD AND SHAKING. SHE STATES TAKING 2 TYLENOL ARTHRITIS AND 1 BENEDRYL AND THIS HELPED HER SYMPTOMS. SHE STATED ALSO TAKING A FEXOFENEDINE THAT MORNING THAT COULD HAVE MADE THE SITUATION NOT AS SEVERE .
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product label issue
Clinical narrative: Patient was given Covid vaccine that are expired 10 weeks after being taken out of the deep freeze. The stickier on the vial was cut off and I didn't see the 10 week expiration date. Patient had no reactions.
Age: 76.0
Sex: F
Vaccine: RSV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given Abrysvo vaccine by the Medical Assistant instead of the Prevnar 20 as requested by the provider. Patient meets criteria for RSV vaccination and has not been previously vaccinated. Patient was notified of error and reported no adverse events related to the vaccine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Patient was given the Pfizer Covid vaccine for 5-11 years old.  Patient is 25 years old.  NO reactions were noticed.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Patient was given the wrong vaccine for age. Pt was given the moderna 6mo-11yr instead of recieving 12plus vaccine.
Age: 2.0
Sex: M
Vaccine: MMRV
Symptoms: Expired product administered
Clinical narrative: DOSE WAS GIVEN AFTER EXPIRATION DATE
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired due to 10 week expiration pulled from ultra cold freezer.    No reactions or problems, no symptoms
Age: 73.0
Sex: M
Vaccine: RSV
Symptoms: Diplegia, Peripheral swelling, Synovial cyst
Clinical narrative: both extremities hip down paralyzed overnight, left leg swell
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product label issue
Clinical narrative: Patient was given Covid vaccine that are expired 10 weeks after being taken out of the deep freeze. The sticker on the vial cas cut off and I didn't see the 10 week expiration date. Patient had no reactions.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Pt was given the dose foe 5-11 years old children.  She is 41 years of age.  No adverse reactions.
Age: 31.0
Sex: F
Vaccine: FLUC4
Symptoms: Burning sensation, Chest discomfort, Crying, Dyspnoea, Emotional distress
Clinical narrative: Patient was given egg-free influenza vaccine at 1030 by Staff Nurse, intramuscular via left deltoid. After 3-5 min, pt stated, "I feel something on my chest" then  experienced difficulty breathing and started to cry. Rapid response initiated at 10:35 am and team responded immediately. Pt transported via wheelchair to patient assisted area (PAA).  Assessed by PAA Staff nurse and Rapid Response Team (RRT) provider. Pt appeared tearful and in emotional distress, but was awake, A&O x4. Pt reports that after receiving egg-free flu vax, she experienced difficulty breathing, numbness/tingling/burning of the entire body, and inability to move. Pt placed onto stretcher for safety and comfort. Vitals taken at 10:40am: BP 142/98, HR 87, T 98.1F, O2sat 100%. Pt evaluated by RRT provider- on exam, heart RRR, lungs clear, pt speaking clearly in full sentences, able to move all extremities, able to take call from workplace. Per MD, suspect panic response. Pt left to rest and revisited by MD after 15 minutes. Situation endorsed to PAA provider for further follow up evaluation. - V/S retaken at 11:05am= BP 111/76, HR 68, 02sat 100%. Pt reports feeling much better  - Pt continued to rest and was under PAA observation. Reevaluation by PAA provider done - appears well on exam, with normal vitals. Suspect panic attack. Advised pt to rest at home for today. ED precaution discussed. Pt understands and agrees with treatment plan.   - All symptoms have resolved after 1 hour's rest in PAA. Able to move and ambulate without any assistance. -  Pt discharged and left PAA at 11:50am in no acute distress.
Age: 31.0
Sex: F
Vaccine: FLUC4
Symptoms: Hypoaesthesia, Mobility decreased, Panic attack, Paraesthesia, Tearfulness
Clinical narrative: Patient was given egg-free influenza vaccine at 1030 by Staff Nurse, intramuscular via left deltoid. After 3-5 min, pt stated, "I feel something on my chest" then  experienced difficulty breathing and started to cry. Rapid response initiated at 10:35 am and team responded immediately. Pt transported via wheelchair to patient assisted area (PAA).  Assessed by PAA Staff nurse and Rapid Response Team (RRT) provider. Pt appeared tearful and in emotional distress, but was awake, A&O x4. Pt reports that after receiving egg-free flu vax, she experienced difficulty breathing, numbness/tingling/burning of the entire body, and inability to move. Pt placed onto stretcher for safety and comfort. Vitals taken at 10:40am: BP 142/98, HR 87, T 98.1F, O2sat 100%. Pt evaluated by RRT provider- on exam, heart RRR, lungs clear, pt speaking clearly in full sentences, able to move all extremities, able to take call from workplace. Per MD, suspect panic response. Pt left to rest and revisited by MD after 15 minutes. Situation endorsed to PAA provider for further follow up evaluation. - V/S retaken at 11:05am= BP 111/76, HR 68, 02sat 100%. Pt reports feeling much better  - Pt continued to rest and was under PAA observation. Reevaluation by PAA provider done - appears well on exam, with normal vitals. Suspect panic attack. Advised pt to rest at home for today. ED precaution discussed. Pt understands and agrees with treatment plan.   - All symptoms have resolved after 1 hour's rest in PAA. Able to move and ambulate without any assistance. -  Pt discharged and left PAA at 11:50am in no acute distress.
Age: 68.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Purulent discharge, Skin discolouration, Staphylococcus test positive, Wound, Wound complication
Clinical narrative: 11/06/23 Developed black & blue which turned into large painful open wound with purulent discharge
Age: 68.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Culture wound positive, Nerve injury, Pain in extremity, Purulent discharge, Scar
Clinical narrative: 11/06/23 Developed black & blue which turned into large painful open wound with purulent discharge
Age: 68.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Skin discolouration, Staphylococcus test positive, Wound, Wound complication, Wrong technique in product usage process
Clinical narrative: 11/06/23 Developed black & blue which turned into large painful open wound with purulent discharge
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dysstasia
Clinical narrative: The patient was administered a Moderna Covid vaccine in our pharmacy several days ago.  About half an hour later, he began experiencing severe dizziness, to the point where he could barely stand up.  He felt as if his legs might give out.  He states that this effect lasted for roughly a day and a half, and then resolved on its own
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arrhythmia, Confusional state, Dysarthria, Dyskinesia, Fatigue
Clinical narrative: Diagnosed with Lyme disease, and experiences symptoms of narcolepsy where patient falls asleep approximately 3-4 times a day at random intervals, experienced involuntary leg movements that was visible to others and he could not walk without assistance. Heart rhythm and pulse is very slow at a rate of 45bpm or less. Chronically exhausted throughout the day with very little effort. Experiences moments of speech slurring and confusion.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Heart rate decreased, Lyme disease, Malaise, Mobility decreased
Clinical narrative: Diagnosed with Lyme disease, and experiences symptoms of narcolepsy where patient falls asleep approximately 3-4 times a day at random intervals, experienced involuntary leg movements that was visible to others and he could not walk without assistance. Heart rhythm and pulse is very slow at a rate of 45bpm or less. Chronically exhausted throughout the day with very little effort. Experiences moments of speech slurring and confusion.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Narcolepsy
Clinical narrative: Diagnosed with Lyme disease, and experiences symptoms of narcolepsy where patient falls asleep approximately 3-4 times a day at random intervals, experienced involuntary leg movements that was visible to others and he could not walk without assistance. Heart rhythm and pulse is very slow at a rate of 45bpm or less. Chronically exhausted throughout the day with very little effort. Experiences moments of speech slurring and confusion.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pruritus, Rash, Swelling face
Clinical narrative: Patient reported the adverse event the next time he was in the pharmacy roughly a month later. He said after he got home he started to get a rash and itch. He said he got some swelling in his face. He called his doctor making him aware. He took some prednisone he had which he said was a saving grace.
Age: 40.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Exposure during pregnancy, Premature delivery, Premature labour, Preterm premature rupture of membranes
Clinical narrative: Pre-term delivery - contractions began at 2 am and water broke at approximately 3:45am.  ESTM delivery date of 2/23/24.  Birth weight was 5 lbs 11 oz.  Geriatric pregnancy.
Age: 58.0
Sex: M
Vaccine: PNC20, TDAP
Symptoms: Injection site erythema, Injection site pain, Local reaction
Clinical narrative: left deltoid area localized reaction ( redness) and pain . started about 5 days after the injection , no fever.
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: Pt was given immunization, then medical assistant realized that it had expired on 02/02/2024.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye pain, Pain in extremity
Clinical narrative: Employee received Moderna Bivalent COVID Vaccine on 2/7/24. Employee was not experiencing any symptoms or signs once vaccine was given or throughout the rest of her shift. Employee came into work on 2/8/24 @ 6:30 A.M. and complained of soreness of the arm that the injection was given. Employee also complained of swolleness of the eyes and her eyes hurting to her Charge Nurse at 12:00 P.M. Nurse notified Administrator at 12:03P.M. Administrator contacted Regional Nurse and Infection Preventionist that recommended employee to see her primary care doctor or go to urgent care/walk-in clinic to get checked out. Sent employee home at 12:15 P.M
Sex: M
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Nurse called to report T/E for GARDASIL 9 and relayed 3 vaccines had been administered.; This spontaneous report was received from a registered nurse (RN) referring to 3 patients of unknown age and gender. The patients' concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.  The vaccine of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) experienced temperature excursion, with temperature excursion 35.02 Fahrenheit (F) for 24 minutes on 28-NOV-2023; and temperature 35.01F for 25 minutes on an unknown date.       On unknown dates, 3 vaccines with temperature excursion of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection were administered to the patients (lot # X005579, expiration date 30-NOV-2024; strength, dose and route were not reported) for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  Follow-up information has been received from the RN on 26-JAN-2024. This spontaneous report was referring to a 36-year-old male patient. On 04-DEC-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot# X004374, expiration date 02-JAN-2025, intramuscular at right arm (reported as right deltoid) (strength and dose were not reported) for prophylaxis which had temperature excursion for a total of 49 minutes to a minimum low temperature of 35 F previously (Product storage error). No adverse events noted by patient during the vaccination (No adverse event). Patient denied any adverse reactions post injection. It was stated the current supply in this excursion of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was supported for continued use.  This case is valid since patient identifier was provided. This is one of 3 reports received from the same reporter.
Sex: M
Vaccine: HEP
Symptoms: No adverse event, Product availability issue, Product dose omission issue
Clinical narrative: No additional AE; The patient called to report that he missed his appointment to receive his second dose of  RECOMBIVAX HB due to the facility being out of stock.; The patient called to report that he missed his appointment to receive his second dose of  RECOMBIVAX HB due to the facility being out of stock.; This spontaneous report has been received from a consumer regarding himself as a male patient with unknown age. The patient's concurrent condition, pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 03-JAN-2024, the patient missed his appointment to receive his second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection (1 ml/series, lot number, expiration date, route of administration and anatomical location were not reported) due to the facility being out of stock (Product dose omission issue and Product availability issue). No symptomatic adverse events were reported. No additional adverse event (AE).  This is one of two reports received from the same reporter.  Lot# is being requested and will be submitted if received.
Sex: U
Vaccine: RV5
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; Product expired 12/10/2023 and was administered 1/22/2024.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 22-JAN-2024, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally (strength, vaccination scheme, anatomical site of vaccination and route of administration were not reported; lot number 1890316, expiration date reported and validated as 10-DEC-2023) as prophylaxis (expired product administered). No additional adverse event (AE) reported.
Sex: F
Vaccine: HPV9
Symptoms: Exposure during pregnancy, Pregnancy test positive, Vaginal discharge
Clinical narrative: HCP called to report administration of GARDASIL 9 to a pregnant patient. Patient received their 3rd dose of GARDASIL 9 on 10JAN2024 and during that time she was on Nora-Be birth control for contraception. HCP stated that the patient called their offi; report vaginal discharge; This spontaneous report was received from nurse and refers to a 30-year-old female.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, administered for immunisation (strength, lot #, expiry date, and route of administration were not provided); and  norethisterone (NORA BE), unk (strength, formulation, lot #, expiry date, route of administration, and indication were not provided).   On 31-JAN-2024, the patient expireinced vaginal discharge and came in for an appointment and a pregnancy test reveal thet the patient was 5 weeks pregnant (Exposure during pregnancy). At the time of reporting, the aoutcome of the event was unknown.  The causal relationship between report vaginal discharge and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.  Lot # is being requested and will be submitted if received.
Sex: U
Vaccine: RV5
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; Inadvertent administration of expired ROTATEQ to a patient. Product expired on 03FEB2024 and was administered to a patient on 05FEB2024; This spontaneous report hass been received from an office manager, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 05-FEB-2024, the patient was inadvertently vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (lot number W014174 was verified to be valid, expiration date reported and confirmed as 03-FEB-2024), administered orally as prophylaxis by a Health Professional (exact dose was not provided) (Expired product administered).  No additional adverse event (AE) was reported.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No reported signs/symptoms of adverse effects.; HCP called for TE evaluation of VARIVAX and other vaccines.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 05-FEB-2024, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (strength, dose, route of administration, lot#, and expiration date were not reported) for prophylaxis. The administered vaccine experienced temperature excursion (TE) before together with other unspecified vaccines (product storage error). No reported signs/symptoms of adverse effects (no adverse event).  Lot# is being requested and will be submitted if received.
Age: 67.0
Sex: M
Vaccine: RSV
Symptoms: Laboratory test abnormal, Pneumonia, Respiratory syncytial virus test positive, Vaccination failure
Clinical narrative: pneumonia; positive for RSV; suspected vaccination failure; This serious case was reported by a other health professional via sales rep and described the occurrence of vaccination failure in a 68-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 07-SEP-2023, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant), pneumonia (Verbatim: pneumonia) (serious criteria hospitalization and GSK medically significant) and respiratory syncytial virus serology positive (Verbatim: positive for RSV) (serious criteria hospitalization). The patient was treated with  (Steroids). The outcome of the vaccination failure was unknown and the outcome of the pneumonia and respiratory syncytial virus serology positive were not reported.   It was unknown if the reporter considered the vaccination failure, pneumonia and respiratory syncytial virus serology positive to be related to Arexvy.     It was unknown if the company considered the vaccination failure, pneumonia and respiratory syncytial virus serology positive to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-FEB-2024 The other health professional reported that the patient had immunized with Arexvy vaccine. The reported that the patient was admitted to the hospital. The reported that he tested positive for RSV and pneumonia. The patient had treated with steroids, oxygen and breathing treatments. The reported that patient followed up with the provider. This case was considered as suspected vaccination failure as details regarding time to onset for RSV   were unknown at the time of reporting. The reporter reported that they might have more patients that have been admitted to the hospital for RSV after immunized with Arexvy vaccine.
Age: 0.33
Sex: F
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave a 4-month-old kinrix; This non-serious case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) for prophylaxis.   Concomitant products included PROQUAD.   On 29-JAN-2024, the patient received Kinrix. On 29-JAN-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Gave a 4-month-old kinrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-JAN-2024 The nurse gave a 4 month old patient Kinrix and Proquad. The reporter did not know which dose of the vaccine was this. The patient received Kinrix below than the recommended age limit, which led to inappropriate age at vaccine administration. The reporter did not consent to follow-up.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Immediate post-injection reaction, Pruritus, Rash
Clinical narrative: For almost a year I was immediately affected with a severe rash and uncontrollable pruritus; For almost a year I was immediately affected with a severe rash and uncontrollable pruritus; This non-serious case was reported by a consumer and described the occurrence of pruritus in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number XG7RF) for prophylaxis.   The patient's past medical history included chickenpox (The patient had Chicken Pox as a child.).   On 16-MAR-2023, the patient received Shingrix. On 16-MAR-2023, immediately after receiving Shingrix, the patient experienced pruritus (Verbatim: For almost a year I was immediately affected with a severe rash and uncontrollable pruritus) and rash (Verbatim: For almost a year I was immediately affected with a severe rash and uncontrollable pruritus). The patient was treated with prednisone. The outcome of the pruritus and rash were not resolved.   It was unknown if the reporter considered the pruritus and rash to be related to Shingrix.     It was unknown if the company considered the pruritus and rash to be related to Shingrix.   Additional Information: GSK Receipt Date: 01-FEB-2024 The patient was reporter The patient reported that she received Shingrix vaccine and immediately affected with severe rash and uncontrollable pruritus that presented an enigma. The reported that at the time of reported the symptoms are ongoing. The she stated that the her encouraged by the pharmacist got the vaccine because of her age and the fact that she had chicken pox at the child.